Cost-effectiveness analysis of second intravenous immunoglobulin infusion versus infliximab for treating IVIG-resistant Kawasaki disease patients

Abstract Objective Intravenous immunoglobulin (IVIG) is a known effective treatment to reduce the incidence of coronary artery aneurysms in Kawasaki disease (KD) patients. However, there has been an increase in IVIG-resistant patients and a lack of clinical trial data to determine the best second tr...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jada M. Johnson, Kit N. Simpson, Annie N. Simpson, Adriana H. Tremoulet, Jane C. Burns
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-11-01
Edice:	Cost Effectiveness and Resource Allocation
Témata:	Pediatrics Persistent fever ICER Comparative effectiveness Coronary artery aneurysm Blood transfusion
On-line přístup:	https://doi.org/10.1186/s12962-025-00674-0
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!